Shivam chemicals Limited has fulfilled its regulatory obligations by submitting the mandatory certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The company filed this compliance document with BSE SME Platform on April 15, 2026, as part of its ongoing regulatory requirements.

Regulatory Compliance Details

The certificate submission relates to the company's dematerialisation activities during Q4FY26. Managing Director Sanjiv Girdharlal Vasant (DIN: 03036854) signed and submitted the compliance document to BSE SME Platform, confirming adherence to SEBI's depositories and participants regulations.

Registrar Confirmation

Cameo Corporate Services Limited, serving as the company's registrar, provided the confirmation certificate dated April 2, 2026. The registrar validated that all securities received from depository participants for dematerialisation during Q4FY26 were properly processed and confirmed to depositories within the required timeframes.

The registrar's certificate confirms several key compliance aspects:

• Securities received for dematerialisation were confirmed (accepted/rejected) to depositories
• All securities comprised in certificates have been listed on stock exchanges where earlier issued securities are listed
• Security certificates received for dematerialisation were mutilated and cancelled after due verification
• Depository names were substituted in the register of members as registered owners within stipulated time limits

Corporate Information

Shivam Chemicals Limited operates from its registered office at 108, Hubtown Solaris, N.S. Phadke Marg, Andheri East, Mumbai 400069. The company maintains its corporate website at www.shivamechem.com and trades on BSE SME Platform under scrip code 544165.

This quarterly certificate submission demonstrates the company's commitment to maintaining regulatory compliance and transparency in its securities handling processes as mandated by SEBI regulations.

Shivam Chemicals Limited has announced multiple strategic business developments under Regulation 30, focusing on portfolio expansion and operational enhancement in the feed ingredients sector.

Feed Ingredients Portfolio Expansion

The company has significantly strengthened its presence in the feed ingredients segment by expanding its product portfolio to include amino acids and feed phosphate products. These products are being sourced through established and reliable supply partnerships based in China and Morocco.

The company noted that these products have received encouraging acceptance from several leading feed manufacturers across India, supporting its efforts to expand its footprint in the animal nutrition sector.

Launch of Shivamin Vitamin Premix Formulations

Shivam Chemicals has introduced customized vitamin premix formulations designed to meet specific nutritional requirements of customers. These formulations are sourced from Sri Lanka and are being marketed in India under the brand name "Shivamin."

This initiative forms part of the company's strategy to diversify its product offerings and provide customized and value-added nutritional solutions to customers in the feed industry.

Commercial Production at Khimsar Unit

In furtherance of its backward integration strategy, Shivam Chemicals has taken on lease a Quick Lime manufacturing unit located at Khimsar, Rajasthan. The company announced that commercial production at the facility has commenced and the unit is currently operating at full capacity.

The facility presently caters to more than 50% of the raw material requirements for the manufacturing operations of the company's subsidiary located at Dahej, Gujarat. The finished products manufactured by the subsidiary are supplied to several major lime-consuming industries situated in the Dahej industrial region.

Strategic Impact

These initiatives are expected to strengthen the company's supply chain, enhance operational efficiencies, and support long-term growth strategy, particularly in the feed ingredients and allied sectors. The developments represent a comprehensive approach to vertical integration and market expansion in the animal nutrition space.

The disclosure was made pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was signed by Managing Director Sanjiv Vasant on 10th March, 2026.